Program
MenACYW conjugate vaccine
Its studies are mostly in Meningococcal Infections · Meningitis, Meningococcal, led by Sanofi.
Furthest: phase 4, since Jun 12, 20237 company-led studies, 0 open or running
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Sanofi | 70 open or running | phase 4since Jun 12, 2023 | Jun 28, 2017 | none ahead |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Jun 28, 2017First study: phase 3 study in Meningitis, MeningococcalFirst studyNCT03205371 · 1,183 enrolled · Korea, Republic of, Mexico, Russian Federation and more
- Mar 19, 2018Phase 3 study in Meningococcal InfectionsNCT03476135 · 91 enrolled · Finland
- May 15, 20182 phase 3 studies in Meningococcal InfectionsNCT03537508, NCT03547271
- Jun 12, 2023Phase 4 study in Meningococcal ImmunisationNCT05929651 · 71 enrolled · Argentina
- Feb 22, 2024Phase 3 study in Meningococcal ImmunisationNCT06284915 · 840 enrolled · Czechia, Denmark, Finland and more
- Aug 14, 2025Phase 3 study in Meningococcal InfectionsNCT07135986 · 1,602 enrolled · China
TargetBeta
A vaccine: it acts on a pathogen, not a human gene.
“MenACYW conjugate vaccine”name, by rule
Studies
All 7 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07135986Meningococcal Infections · China | 3 | Completed | May 1, 2026 | 1,602 |
| NCT06284915Meningococcal Immunisation · Czechia, Denmark, Finland and more | 3 | Completed | Nov 14, 2025 | 840 |
| NCT05929651Meningococcal Immunisation · Argentina | 4 | Completed | Sep 9, 2024 | 71 |
| NCT03547271Meningococcal Infections · Czechia, Finland, Italy and more | 3 | Completed | May 17, 2023 | 1,660 |
| NCT03537508Meningococcal Infections · United States, Puerto Rico | 3 | Completed | Sep 22, 2023 | 2,627 |
| NCT03476135Meningococcal Infections · Finland | 3 | Completed | Sep 10, 2018 | 91 |
| NCT03205371Meningitis, Meningococcal · Korea, Republic of, Mexico, Russian Federation and more | 3 | Completed | Jul 19, 2018 | 1,183 |
How it is read
Names in the registry
- “MenACYW conjugate vaccine”, 8 entries
Conditions, from the studies’ own filings
- Meningococcal Infections, 4 studies
- Meningitis, Meningococcal, 1 study
First seen by our ledger Nov 14, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.